nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbamazepine—UGT2B7—urinary bladder cancer	0.442	1	CbGaD
Carbamazepine—RALBP1—Doxorubicin—urinary bladder cancer	0.099	0.268	CbGbCtD
Carbamazepine—UGT2B7—Epirubicin—urinary bladder cancer	0.0372	0.101	CbGbCtD
Carbamazepine—CYP2B6—Thiotepa—urinary bladder cancer	0.0357	0.0968	CbGbCtD
Carbamazepine—ABCB1—Mitomycin—urinary bladder cancer	0.0241	0.0655	CbGbCtD
Carbamazepine—ABCC2—Carboplatin—urinary bladder cancer	0.0181	0.0492	CbGbCtD
Carbamazepine—ABCC2—Cisplatin—urinary bladder cancer	0.0155	0.042	CbGbCtD
Carbamazepine—ABCC2—Etoposide—urinary bladder cancer	0.0152	0.0413	CbGbCtD
Carbamazepine—CYP3A4—Thiotepa—urinary bladder cancer	0.011	0.0297	CbGbCtD
Carbamazepine—ABCC2—Doxorubicin—urinary bladder cancer	0.0104	0.0281	CbGbCtD
Carbamazepine—ABCC2—Methotrexate—urinary bladder cancer	0.0101	0.0273	CbGbCtD
Carbamazepine—CYP2B6—Cisplatin—urinary bladder cancer	0.00985	0.0267	CbGbCtD
Carbamazepine—CYP2C8—Fluorouracil—urinary bladder cancer	0.00878	0.0238	CbGbCtD
Carbamazepine—CYP3A5—Etoposide—urinary bladder cancer	0.00762	0.0207	CbGbCtD
Carbamazepine—CYP2C8—Etoposide—urinary bladder cancer	0.00733	0.0199	CbGbCtD
Carbamazepine—ABCB1—Gemcitabine—urinary bladder cancer	0.00695	0.0188	CbGbCtD
Carbamazepine—CYP1A2—Fluorouracil—urinary bladder cancer	0.0068	0.0184	CbGbCtD
Carbamazepine—CYP2B6—Doxorubicin—urinary bladder cancer	0.0066	0.0179	CbGbCtD
Carbamazepine—CYP2C9—Fluorouracil—urinary bladder cancer	0.00613	0.0166	CbGbCtD
Carbamazepine—CYP1A2—Etoposide—urinary bladder cancer	0.00567	0.0154	CbGbCtD
Carbamazepine—CYP2C9—Cisplatin—urinary bladder cancer	0.0052	0.0141	CbGbCtD
Carbamazepine—ABCB1—Cisplatin—urinary bladder cancer	0.00505	0.0137	CbGbCtD
Carbamazepine—ABCB1—Etoposide—urinary bladder cancer	0.00496	0.0135	CbGbCtD
Carbamazepine—ABCB1—Doxorubicin—urinary bladder cancer	0.00338	0.00918	CbGbCtD
Carbamazepine—ABCB1—Methotrexate—urinary bladder cancer	0.00328	0.00889	CbGbCtD
Carbamazepine—CYP3A4—Etoposide—urinary bladder cancer	0.00297	0.00806	CbGbCtD
Carbamazepine—CYP3A4—Doxorubicin—urinary bladder cancer	0.00203	0.0055	CbGbCtD
Carbamazepine—CYP2C19—urine—urinary bladder cancer	0.0018	0.0631	CbGeAlD
Carbamazepine—CYP1A2—urine—urinary bladder cancer	0.00147	0.0515	CbGeAlD
Carbamazepine—SCN9A—prostate gland—urinary bladder cancer	0.00145	0.0508	CbGeAlD
Carbamazepine—RALBP1—prostate gland—urinary bladder cancer	0.0014	0.0491	CbGeAlD
Carbamazepine—UGT2B7—prostate gland—urinary bladder cancer	0.0014	0.0491	CbGeAlD
Carbamazepine—CYP2C9—urine—urinary bladder cancer	0.0014	0.0489	CbGeAlD
Carbamazepine—SCN4A—prostate gland—urinary bladder cancer	0.0013	0.0453	CbGeAlD
Carbamazepine—RALBP1—seminal vesicle—urinary bladder cancer	0.00119	0.0416	CbGeAlD
Carbamazepine—CYP3A4—urine—urinary bladder cancer	0.00107	0.0373	CbGeAlD
Carbamazepine—RALBP1—smooth muscle tissue—urinary bladder cancer	0.000994	0.0348	CbGeAlD
Carbamazepine—UGT2B7—renal system—urinary bladder cancer	0.000957	0.0335	CbGeAlD
Carbamazepine—RALBP1—renal system—urinary bladder cancer	0.000957	0.0335	CbGeAlD
Carbamazepine—RALBP1—urethra—urinary bladder cancer	0.00094	0.0329	CbGeAlD
Carbamazepine—SCN4A—renal system—urinary bladder cancer	0.000883	0.0309	CbGeAlD
Carbamazepine—UGT2B7—female reproductive system—urinary bladder cancer	0.000767	0.0268	CbGeAlD
Carbamazepine—RALBP1—female reproductive system—urinary bladder cancer	0.000767	0.0268	CbGeAlD
Carbamazepine—ABCC2—prostate gland—urinary bladder cancer	0.000753	0.0264	CbGeAlD
Carbamazepine—RALBP1—vagina—urinary bladder cancer	0.000693	0.0243	CbGeAlD
Carbamazepine—ABCC2—renal system—urinary bladder cancer	0.000513	0.018	CbGeAlD
Carbamazepine—CYP3A5—prostate gland—urinary bladder cancer	0.00051	0.0178	CbGeAlD
Carbamazepine—SCN5A—vagina—urinary bladder cancer	0.000496	0.0174	CbGeAlD
Carbamazepine—SCN9A—lymph node—urinary bladder cancer	0.000464	0.0162	CbGeAlD
Carbamazepine—RALBP1—lymph node—urinary bladder cancer	0.000449	0.0157	CbGeAlD
Carbamazepine—ABCC2—female reproductive system—urinary bladder cancer	0.000411	0.0144	CbGeAlD
Carbamazepine—CYP2C8—renal system—urinary bladder cancer	0.000385	0.0135	CbGeAlD
Carbamazepine—CYP1A2—renal system—urinary bladder cancer	0.00036	0.0126	CbGeAlD
Carbamazepine—CYP3A5—renal system—urinary bladder cancer	0.000348	0.0122	CbGeAlD
Carbamazepine—CYP2B6—renal system—urinary bladder cancer	0.000345	0.0121	CbGeAlD
Carbamazepine—CYP2C19—vagina—urinary bladder cancer	0.00032	0.0112	CbGeAlD
Carbamazepine—CYP2C8—female reproductive system—urinary bladder cancer	0.000308	0.0108	CbGeAlD
Carbamazepine—CYP2C8—vagina—urinary bladder cancer	0.000279	0.00976	CbGeAlD
Carbamazepine—CYP2B6—female reproductive system—urinary bladder cancer	0.000277	0.00968	CbGeAlD
Carbamazepine—CYP2C9—female reproductive system—urinary bladder cancer	0.000274	0.00959	CbGeAlD
Carbamazepine—ABCB1—prostate gland—urinary bladder cancer	0.000271	0.00948	CbGeAlD
Carbamazepine—CYP3A4—renal system—urinary bladder cancer	0.000261	0.00913	CbGeAlD
Carbamazepine—CYP3A5—vagina—urinary bladder cancer	0.000252	0.00881	CbGeAlD
Carbamazepine—CYP2B6—vagina—urinary bladder cancer	0.00025	0.00876	CbGeAlD
Carbamazepine—ABCC2—lymph node—urinary bladder cancer	0.000241	0.00842	CbGeAlD
Carbamazepine—ABCB1—seminal vesicle—urinary bladder cancer	0.000229	0.00802	CbGeAlD
Carbamazepine—CYP3A4—female reproductive system—urinary bladder cancer	0.000209	0.00731	CbGeAlD
Carbamazepine—ABCB1—epithelium—urinary bladder cancer	0.000199	0.00697	CbGeAlD
Carbamazepine—Nepafenac—PTGS2—urinary bladder cancer	0.000189	0.275	CrCbGaD
Carbamazepine—Magnesium salicylate—PTGS2—urinary bladder cancer	0.000185	0.268	CrCbGaD
Carbamazepine—ABCB1—renal system—urinary bladder cancer	0.000185	0.00646	CbGeAlD
Carbamazepine—ABCB1—urethra—urinary bladder cancer	0.000181	0.00635	CbGeAlD
Carbamazepine—Salsalate—PTGS2—urinary bladder cancer	0.000157	0.228	CrCbGaD
Carbamazepine—Oxaprozin—PTGS2—urinary bladder cancer	0.000157	0.228	CrCbGaD
Carbamazepine—ABCB1—female reproductive system—urinary bladder cancer	0.000148	0.00517	CbGeAlD
Carbamazepine—ABCB1—vagina—urinary bladder cancer	0.000134	0.00468	CbGeAlD
Carbamazepine—ABCB1—lymph node—urinary bladder cancer	8.65e-05	0.00303	CbGeAlD
Carbamazepine—Body temperature increased—Etoposide—urinary bladder cancer	5.02e-05	0.000448	CcSEcCtD
Carbamazepine—Abdominal pain—Etoposide—urinary bladder cancer	5.02e-05	0.000448	CcSEcCtD
Carbamazepine—Urinary tract infection—Doxorubicin—urinary bladder cancer	5.02e-05	0.000448	CcSEcCtD
Carbamazepine—Conjunctivitis—Doxorubicin—urinary bladder cancer	5.02e-05	0.000448	CcSEcCtD
Carbamazepine—Hepatitis—Epirubicin—urinary bladder cancer	5.01e-05	0.000447	CcSEcCtD
Carbamazepine—Eye disorder—Methotrexate—urinary bladder cancer	5e-05	0.000447	CcSEcCtD
Carbamazepine—Diarrhoea—Fluorouracil—urinary bladder cancer	5e-05	0.000447	CcSEcCtD
Carbamazepine—Tinnitus—Methotrexate—urinary bladder cancer	4.99e-05	0.000446	CcSEcCtD
Carbamazepine—Asthenia—Cisplatin—urinary bladder cancer	4.97e-05	0.000444	CcSEcCtD
Carbamazepine—Pharyngitis—Epirubicin—urinary bladder cancer	4.97e-05	0.000444	CcSEcCtD
Carbamazepine—Cardiac disorder—Methotrexate—urinary bladder cancer	4.96e-05	0.000444	CcSEcCtD
Carbamazepine—Urinary tract disorder—Epirubicin—urinary bladder cancer	4.94e-05	0.000442	CcSEcCtD
Carbamazepine—Oedema peripheral—Epirubicin—urinary bladder cancer	4.93e-05	0.000441	CcSEcCtD
Carbamazepine—Haematuria—Doxorubicin—urinary bladder cancer	4.92e-05	0.00044	CcSEcCtD
Carbamazepine—Connective tissue disorder—Epirubicin—urinary bladder cancer	4.92e-05	0.00044	CcSEcCtD
Carbamazepine—Urethral disorder—Epirubicin—urinary bladder cancer	4.91e-05	0.000438	CcSEcCtD
Carbamazepine—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	4.88e-05	0.000436	CcSEcCtD
Carbamazepine—Angiopathy—Methotrexate—urinary bladder cancer	4.85e-05	0.000434	CcSEcCtD
Carbamazepine—Sinusitis—Doxorubicin—urinary bladder cancer	4.84e-05	0.000433	CcSEcCtD
Carbamazepine—Immune system disorder—Methotrexate—urinary bladder cancer	4.83e-05	0.000432	CcSEcCtD
Carbamazepine—Dizziness—Fluorouracil—urinary bladder cancer	4.83e-05	0.000432	CcSEcCtD
Carbamazepine—Mediastinal disorder—Methotrexate—urinary bladder cancer	4.82e-05	0.000431	CcSEcCtD
Carbamazepine—Agranulocytosis—Doxorubicin—urinary bladder cancer	4.81e-05	0.00043	CcSEcCtD
Carbamazepine—Chills—Methotrexate—urinary bladder cancer	4.8e-05	0.000429	CcSEcCtD
Carbamazepine—Diarrhoea—Cisplatin—urinary bladder cancer	4.74e-05	0.000423	CcSEcCtD
Carbamazepine—Erythema multiforme—Epirubicin—urinary bladder cancer	4.73e-05	0.000423	CcSEcCtD
Carbamazepine—Alopecia—Methotrexate—urinary bladder cancer	4.73e-05	0.000422	CcSEcCtD
Carbamazepine—Vomiting—Gemcitabine—urinary bladder cancer	4.72e-05	0.000422	CcSEcCtD
Carbamazepine—Bradycardia—Doxorubicin—urinary bladder cancer	4.72e-05	0.000421	CcSEcCtD
Carbamazepine—Mental disorder—Methotrexate—urinary bladder cancer	4.69e-05	0.000419	CcSEcCtD
Carbamazepine—Rash—Gemcitabine—urinary bladder cancer	4.68e-05	0.000419	CcSEcCtD
Carbamazepine—Dermatitis—Gemcitabine—urinary bladder cancer	4.68e-05	0.000418	CcSEcCtD
Carbamazepine—Eye disorder—Epirubicin—urinary bladder cancer	4.68e-05	0.000418	CcSEcCtD
Carbamazepine—Hypersensitivity—Etoposide—urinary bladder cancer	4.67e-05	0.000418	CcSEcCtD
Carbamazepine—Tinnitus—Epirubicin—urinary bladder cancer	4.67e-05	0.000417	CcSEcCtD
Carbamazepine—Erythema—Methotrexate—urinary bladder cancer	4.66e-05	0.000416	CcSEcCtD
Carbamazepine—Malnutrition—Methotrexate—urinary bladder cancer	4.66e-05	0.000416	CcSEcCtD
Carbamazepine—Headache—Gemcitabine—urinary bladder cancer	4.65e-05	0.000416	CcSEcCtD
Carbamazepine—Flushing—Epirubicin—urinary bladder cancer	4.65e-05	0.000415	CcSEcCtD
Carbamazepine—Cardiac disorder—Epirubicin—urinary bladder cancer	4.65e-05	0.000415	CcSEcCtD
Carbamazepine—Vomiting—Fluorouracil—urinary bladder cancer	4.64e-05	0.000415	CcSEcCtD
Carbamazepine—Rhinitis—Doxorubicin—urinary bladder cancer	4.64e-05	0.000415	CcSEcCtD
Carbamazepine—Hepatitis—Doxorubicin—urinary bladder cancer	4.63e-05	0.000414	CcSEcCtD
Carbamazepine—Rash—Fluorouracil—urinary bladder cancer	4.61e-05	0.000412	CcSEcCtD
Carbamazepine—Dermatitis—Fluorouracil—urinary bladder cancer	4.6e-05	0.000411	CcSEcCtD
Carbamazepine—Pharyngitis—Doxorubicin—urinary bladder cancer	4.6e-05	0.000411	CcSEcCtD
Carbamazepine—Headache—Fluorouracil—urinary bladder cancer	4.58e-05	0.000409	CcSEcCtD
Carbamazepine—Urinary tract disorder—Doxorubicin—urinary bladder cancer	4.57e-05	0.000409	CcSEcCtD
Carbamazepine—Oedema peripheral—Doxorubicin—urinary bladder cancer	4.56e-05	0.000408	CcSEcCtD
Carbamazepine—Dysgeusia—Methotrexate—urinary bladder cancer	4.56e-05	0.000407	CcSEcCtD
Carbamazepine—Asthenia—Etoposide—urinary bladder cancer	4.55e-05	0.000407	CcSEcCtD
Carbamazepine—Connective tissue disorder—Doxorubicin—urinary bladder cancer	4.55e-05	0.000407	CcSEcCtD
Carbamazepine—Angiopathy—Epirubicin—urinary bladder cancer	4.54e-05	0.000406	CcSEcCtD
Carbamazepine—Urethral disorder—Doxorubicin—urinary bladder cancer	4.54e-05	0.000406	CcSEcCtD
Carbamazepine—Immune system disorder—Epirubicin—urinary bladder cancer	4.52e-05	0.000404	CcSEcCtD
Carbamazepine—Mediastinal disorder—Epirubicin—urinary bladder cancer	4.51e-05	0.000403	CcSEcCtD
Carbamazepine—Back pain—Methotrexate—urinary bladder cancer	4.5e-05	0.000402	CcSEcCtD
Carbamazepine—Chills—Epirubicin—urinary bladder cancer	4.49e-05	0.000401	CcSEcCtD
Carbamazepine—Pruritus—Etoposide—urinary bladder cancer	4.49e-05	0.000401	CcSEcCtD
Carbamazepine—Arrhythmia—Epirubicin—urinary bladder cancer	4.47e-05	0.0004	CcSEcCtD
Carbamazepine—Alopecia—Epirubicin—urinary bladder cancer	4.42e-05	0.000395	CcSEcCtD
Carbamazepine—Nausea—Gemcitabine—urinary bladder cancer	4.41e-05	0.000394	CcSEcCtD
Carbamazepine—Vomiting—Cisplatin—urinary bladder cancer	4.4e-05	0.000393	CcSEcCtD
Carbamazepine—Vision blurred—Methotrexate—urinary bladder cancer	4.39e-05	0.000392	CcSEcCtD
Carbamazepine—Mental disorder—Epirubicin—urinary bladder cancer	4.39e-05	0.000392	CcSEcCtD
Carbamazepine—Erythema multiforme—Doxorubicin—urinary bladder cancer	4.38e-05	0.000391	CcSEcCtD
Carbamazepine—Rash—Cisplatin—urinary bladder cancer	4.37e-05	0.00039	CcSEcCtD
Carbamazepine—Dermatitis—Cisplatin—urinary bladder cancer	4.36e-05	0.00039	CcSEcCtD
Carbamazepine—Malnutrition—Epirubicin—urinary bladder cancer	4.36e-05	0.000389	CcSEcCtD
Carbamazepine—Erythema—Epirubicin—urinary bladder cancer	4.36e-05	0.000389	CcSEcCtD
Carbamazepine—Diarrhoea—Etoposide—urinary bladder cancer	4.34e-05	0.000388	CcSEcCtD
Carbamazepine—Nausea—Fluorouracil—urinary bladder cancer	4.34e-05	0.000388	CcSEcCtD
Carbamazepine—Eye disorder—Doxorubicin—urinary bladder cancer	4.33e-05	0.000387	CcSEcCtD
Carbamazepine—Tinnitus—Doxorubicin—urinary bladder cancer	4.32e-05	0.000386	CcSEcCtD
Carbamazepine—Anaemia—Methotrexate—urinary bladder cancer	4.3e-05	0.000385	CcSEcCtD
Carbamazepine—Cardiac disorder—Doxorubicin—urinary bladder cancer	4.3e-05	0.000384	CcSEcCtD
Carbamazepine—Flushing—Doxorubicin—urinary bladder cancer	4.3e-05	0.000384	CcSEcCtD
Carbamazepine—Tension—Epirubicin—urinary bladder cancer	4.28e-05	0.000382	CcSEcCtD
Carbamazepine—Dysgeusia—Epirubicin—urinary bladder cancer	4.27e-05	0.000381	CcSEcCtD
Carbamazepine—Nervousness—Epirubicin—urinary bladder cancer	4.23e-05	0.000378	CcSEcCtD
Carbamazepine—Back pain—Epirubicin—urinary bladder cancer	4.21e-05	0.000377	CcSEcCtD
Carbamazepine—Angiopathy—Doxorubicin—urinary bladder cancer	4.2e-05	0.000376	CcSEcCtD
Carbamazepine—Dizziness—Etoposide—urinary bladder cancer	4.2e-05	0.000375	CcSEcCtD
Carbamazepine—Muscle spasms—Epirubicin—urinary bladder cancer	4.19e-05	0.000374	CcSEcCtD
Carbamazepine—Immune system disorder—Doxorubicin—urinary bladder cancer	4.18e-05	0.000374	CcSEcCtD
Carbamazepine—Vertigo—Methotrexate—urinary bladder cancer	4.18e-05	0.000374	CcSEcCtD
Carbamazepine—Mediastinal disorder—Doxorubicin—urinary bladder cancer	4.17e-05	0.000373	CcSEcCtD
Carbamazepine—Leukopenia—Methotrexate—urinary bladder cancer	4.17e-05	0.000372	CcSEcCtD
Carbamazepine—Chills—Doxorubicin—urinary bladder cancer	4.16e-05	0.000371	CcSEcCtD
Carbamazepine—Arrhythmia—Doxorubicin—urinary bladder cancer	4.14e-05	0.00037	CcSEcCtD
Carbamazepine—Nausea—Cisplatin—urinary bladder cancer	4.11e-05	0.000368	CcSEcCtD
Carbamazepine—Vision blurred—Epirubicin—urinary bladder cancer	4.11e-05	0.000367	CcSEcCtD
Carbamazepine—Alopecia—Doxorubicin—urinary bladder cancer	4.09e-05	0.000366	CcSEcCtD
Carbamazepine—Mental disorder—Doxorubicin—urinary bladder cancer	4.06e-05	0.000363	CcSEcCtD
Carbamazepine—Convulsion—Methotrexate—urinary bladder cancer	4.03e-05	0.000361	CcSEcCtD
Carbamazepine—Vomiting—Etoposide—urinary bladder cancer	4.03e-05	0.00036	CcSEcCtD
Carbamazepine—Erythema—Doxorubicin—urinary bladder cancer	4.03e-05	0.00036	CcSEcCtD
Carbamazepine—Malnutrition—Doxorubicin—urinary bladder cancer	4.03e-05	0.00036	CcSEcCtD
Carbamazepine—Anaemia—Epirubicin—urinary bladder cancer	4.03e-05	0.00036	CcSEcCtD
Carbamazepine—Agitation—Epirubicin—urinary bladder cancer	4e-05	0.000358	CcSEcCtD
Carbamazepine—Rash—Etoposide—urinary bladder cancer	4e-05	0.000357	CcSEcCtD
Carbamazepine—Dermatitis—Etoposide—urinary bladder cancer	4e-05	0.000357	CcSEcCtD
Carbamazepine—Headache—Etoposide—urinary bladder cancer	3.97e-05	0.000355	CcSEcCtD
Carbamazepine—Arthralgia—Methotrexate—urinary bladder cancer	3.96e-05	0.000354	CcSEcCtD
Carbamazepine—Chest pain—Methotrexate—urinary bladder cancer	3.96e-05	0.000354	CcSEcCtD
Carbamazepine—Myalgia—Methotrexate—urinary bladder cancer	3.96e-05	0.000354	CcSEcCtD
Carbamazepine—Tension—Doxorubicin—urinary bladder cancer	3.96e-05	0.000354	CcSEcCtD
Carbamazepine—Dysgeusia—Doxorubicin—urinary bladder cancer	3.95e-05	0.000353	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	3.94e-05	0.000352	CcSEcCtD
Carbamazepine—Nervousness—Doxorubicin—urinary bladder cancer	3.92e-05	0.00035	CcSEcCtD
Carbamazepine—Vertigo—Epirubicin—urinary bladder cancer	3.91e-05	0.00035	CcSEcCtD
Carbamazepine—Syncope—Epirubicin—urinary bladder cancer	3.91e-05	0.000349	CcSEcCtD
Carbamazepine—Leukopenia—Epirubicin—urinary bladder cancer	3.9e-05	0.000349	CcSEcCtD
Carbamazepine—Back pain—Doxorubicin—urinary bladder cancer	3.9e-05	0.000349	CcSEcCtD
Carbamazepine—Muscle spasms—Doxorubicin—urinary bladder cancer	3.88e-05	0.000346	CcSEcCtD
Carbamazepine—Confusional state—Methotrexate—urinary bladder cancer	3.83e-05	0.000342	CcSEcCtD
Carbamazepine—Loss of consciousness—Epirubicin—urinary bladder cancer	3.83e-05	0.000342	CcSEcCtD
Carbamazepine—Anaphylactic shock—Methotrexate—urinary bladder cancer	3.8e-05	0.00034	CcSEcCtD
Carbamazepine—Vision blurred—Doxorubicin—urinary bladder cancer	3.8e-05	0.00034	CcSEcCtD
Carbamazepine—Convulsion—Epirubicin—urinary bladder cancer	3.78e-05	0.000337	CcSEcCtD
Carbamazepine—Infection—Methotrexate—urinary bladder cancer	3.78e-05	0.000337	CcSEcCtD
Carbamazepine—Nausea—Etoposide—urinary bladder cancer	3.77e-05	0.000337	CcSEcCtD
Carbamazepine—Hypertension—Epirubicin—urinary bladder cancer	3.76e-05	0.000336	CcSEcCtD
Carbamazepine—Nervous system disorder—Methotrexate—urinary bladder cancer	3.73e-05	0.000333	CcSEcCtD
Carbamazepine—Anaemia—Doxorubicin—urinary bladder cancer	3.73e-05	0.000333	CcSEcCtD
Carbamazepine—Thrombocytopenia—Methotrexate—urinary bladder cancer	3.72e-05	0.000332	CcSEcCtD
Carbamazepine—Myalgia—Epirubicin—urinary bladder cancer	3.71e-05	0.000332	CcSEcCtD
Carbamazepine—Arthralgia—Epirubicin—urinary bladder cancer	3.71e-05	0.000332	CcSEcCtD
Carbamazepine—Chest pain—Epirubicin—urinary bladder cancer	3.71e-05	0.000332	CcSEcCtD
Carbamazepine—Agitation—Doxorubicin—urinary bladder cancer	3.71e-05	0.000331	CcSEcCtD
Carbamazepine—Anxiety—Epirubicin—urinary bladder cancer	3.7e-05	0.00033	CcSEcCtD
Carbamazepine—Skin disorder—Methotrexate—urinary bladder cancer	3.69e-05	0.00033	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	3.68e-05	0.000329	CcSEcCtD
Carbamazepine—Hyperhidrosis—Methotrexate—urinary bladder cancer	3.67e-05	0.000328	CcSEcCtD
Carbamazepine—Dry mouth—Epirubicin—urinary bladder cancer	3.63e-05	0.000324	CcSEcCtD
Carbamazepine—Vertigo—Doxorubicin—urinary bladder cancer	3.62e-05	0.000324	CcSEcCtD
Carbamazepine—Anorexia—Methotrexate—urinary bladder cancer	3.62e-05	0.000324	CcSEcCtD
Carbamazepine—Syncope—Doxorubicin—urinary bladder cancer	3.62e-05	0.000323	CcSEcCtD
Carbamazepine—Leukopenia—Doxorubicin—urinary bladder cancer	3.61e-05	0.000322	CcSEcCtD
Carbamazepine—Confusional state—Epirubicin—urinary bladder cancer	3.59e-05	0.00032	CcSEcCtD
Carbamazepine—Oedema—Epirubicin—urinary bladder cancer	3.56e-05	0.000318	CcSEcCtD
Carbamazepine—Anaphylactic shock—Epirubicin—urinary bladder cancer	3.56e-05	0.000318	CcSEcCtD
Carbamazepine—Hypotension—Methotrexate—urinary bladder cancer	3.55e-05	0.000317	CcSEcCtD
Carbamazepine—Loss of consciousness—Doxorubicin—urinary bladder cancer	3.54e-05	0.000317	CcSEcCtD
Carbamazepine—Infection—Epirubicin—urinary bladder cancer	3.53e-05	0.000316	CcSEcCtD
Carbamazepine—Shock—Epirubicin—urinary bladder cancer	3.5e-05	0.000313	CcSEcCtD
Carbamazepine—Convulsion—Doxorubicin—urinary bladder cancer	3.49e-05	0.000312	CcSEcCtD
Carbamazepine—Nervous system disorder—Epirubicin—urinary bladder cancer	3.49e-05	0.000312	CcSEcCtD
Carbamazepine—Thrombocytopenia—Epirubicin—urinary bladder cancer	3.48e-05	0.000311	CcSEcCtD
Carbamazepine—Hypertension—Doxorubicin—urinary bladder cancer	3.48e-05	0.000311	CcSEcCtD
Carbamazepine—Tachycardia—Epirubicin—urinary bladder cancer	3.47e-05	0.00031	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	3.46e-05	0.000309	CcSEcCtD
Carbamazepine—Skin disorder—Epirubicin—urinary bladder cancer	3.45e-05	0.000309	CcSEcCtD
Carbamazepine—Hyperhidrosis—Epirubicin—urinary bladder cancer	3.44e-05	0.000307	CcSEcCtD
Carbamazepine—Insomnia—Methotrexate—urinary bladder cancer	3.44e-05	0.000307	CcSEcCtD
Carbamazepine—Chest pain—Doxorubicin—urinary bladder cancer	3.43e-05	0.000307	CcSEcCtD
Carbamazepine—Arthralgia—Doxorubicin—urinary bladder cancer	3.43e-05	0.000307	CcSEcCtD
Carbamazepine—Myalgia—Doxorubicin—urinary bladder cancer	3.43e-05	0.000307	CcSEcCtD
Carbamazepine—Anxiety—Doxorubicin—urinary bladder cancer	3.42e-05	0.000306	CcSEcCtD
Carbamazepine—Paraesthesia—Methotrexate—urinary bladder cancer	3.41e-05	0.000305	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	3.41e-05	0.000305	CcSEcCtD
Carbamazepine—Anorexia—Epirubicin—urinary bladder cancer	3.39e-05	0.000303	CcSEcCtD
Carbamazepine—Dyspnoea—Methotrexate—urinary bladder cancer	3.39e-05	0.000303	CcSEcCtD
Carbamazepine—Somnolence—Methotrexate—urinary bladder cancer	3.38e-05	0.000302	CcSEcCtD
Carbamazepine—Dry mouth—Doxorubicin—urinary bladder cancer	3.36e-05	0.0003	CcSEcCtD
Carbamazepine—Dyspepsia—Methotrexate—urinary bladder cancer	3.35e-05	0.000299	CcSEcCtD
Carbamazepine—Hypotension—Epirubicin—urinary bladder cancer	3.32e-05	0.000297	CcSEcCtD
Carbamazepine—Confusional state—Doxorubicin—urinary bladder cancer	3.32e-05	0.000296	CcSEcCtD
Carbamazepine—Decreased appetite—Methotrexate—urinary bladder cancer	3.3e-05	0.000295	CcSEcCtD
Carbamazepine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	3.29e-05	0.000294	CcSEcCtD
Carbamazepine—Oedema—Doxorubicin—urinary bladder cancer	3.29e-05	0.000294	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	3.28e-05	0.000293	CcSEcCtD
Carbamazepine—Fatigue—Methotrexate—urinary bladder cancer	3.28e-05	0.000293	CcSEcCtD
Carbamazepine—Infection—Doxorubicin—urinary bladder cancer	3.27e-05	0.000292	CcSEcCtD
Carbamazepine—Pain—Methotrexate—urinary bladder cancer	3.25e-05	0.00029	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	3.24e-05	0.00029	CcSEcCtD
Carbamazepine—Shock—Doxorubicin—urinary bladder cancer	3.24e-05	0.000289	CcSEcCtD
Carbamazepine—Nervous system disorder—Doxorubicin—urinary bladder cancer	3.23e-05	0.000288	CcSEcCtD
Carbamazepine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	3.22e-05	0.000288	CcSEcCtD
Carbamazepine—Insomnia—Epirubicin—urinary bladder cancer	3.22e-05	0.000287	CcSEcCtD
Carbamazepine—Tachycardia—Doxorubicin—urinary bladder cancer	3.21e-05	0.000287	CcSEcCtD
Carbamazepine—Skin disorder—Doxorubicin—urinary bladder cancer	3.2e-05	0.000286	CcSEcCtD
Carbamazepine—Paraesthesia—Epirubicin—urinary bladder cancer	3.19e-05	0.000285	CcSEcCtD
Carbamazepine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	3.18e-05	0.000284	CcSEcCtD
Carbamazepine—Dyspnoea—Epirubicin—urinary bladder cancer	3.17e-05	0.000283	CcSEcCtD
Carbamazepine—Somnolence—Epirubicin—urinary bladder cancer	3.16e-05	0.000283	CcSEcCtD
Carbamazepine—Anorexia—Doxorubicin—urinary bladder cancer	3.14e-05	0.00028	CcSEcCtD
Carbamazepine—Feeling abnormal—Methotrexate—urinary bladder cancer	3.13e-05	0.00028	CcSEcCtD
Carbamazepine—Dyspepsia—Epirubicin—urinary bladder cancer	3.13e-05	0.00028	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	3.11e-05	0.000278	CcSEcCtD
Carbamazepine—Decreased appetite—Epirubicin—urinary bladder cancer	3.09e-05	0.000276	CcSEcCtD
Carbamazepine—Hypotension—Doxorubicin—urinary bladder cancer	3.07e-05	0.000275	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	3.07e-05	0.000274	CcSEcCtD
Carbamazepine—Fatigue—Epirubicin—urinary bladder cancer	3.07e-05	0.000274	CcSEcCtD
Carbamazepine—Pain—Epirubicin—urinary bladder cancer	3.04e-05	0.000272	CcSEcCtD
Carbamazepine—Constipation—Epirubicin—urinary bladder cancer	3.04e-05	0.000272	CcSEcCtD
Carbamazepine—Urticaria—Methotrexate—urinary bladder cancer	3.02e-05	0.00027	CcSEcCtD
Carbamazepine—Body temperature increased—Methotrexate—urinary bladder cancer	3e-05	0.000268	CcSEcCtD
Carbamazepine—Abdominal pain—Methotrexate—urinary bladder cancer	3e-05	0.000268	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	3e-05	0.000268	CcSEcCtD
Carbamazepine—Insomnia—Doxorubicin—urinary bladder cancer	2.98e-05	0.000266	CcSEcCtD
Carbamazepine—Paraesthesia—Doxorubicin—urinary bladder cancer	2.95e-05	0.000264	CcSEcCtD
Carbamazepine—Dyspnoea—Doxorubicin—urinary bladder cancer	2.93e-05	0.000262	CcSEcCtD
Carbamazepine—Feeling abnormal—Epirubicin—urinary bladder cancer	2.93e-05	0.000262	CcSEcCtD
Carbamazepine—Somnolence—Doxorubicin—urinary bladder cancer	2.93e-05	0.000261	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	2.91e-05	0.00026	CcSEcCtD
Carbamazepine—Dyspepsia—Doxorubicin—urinary bladder cancer	2.9e-05	0.000259	CcSEcCtD
Carbamazepine—Decreased appetite—Doxorubicin—urinary bladder cancer	2.86e-05	0.000256	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	2.84e-05	0.000254	CcSEcCtD
Carbamazepine—Fatigue—Doxorubicin—urinary bladder cancer	2.84e-05	0.000254	CcSEcCtD
Carbamazepine—Urticaria—Epirubicin—urinary bladder cancer	2.83e-05	0.000252	CcSEcCtD
Carbamazepine—Constipation—Doxorubicin—urinary bladder cancer	2.81e-05	0.000251	CcSEcCtD
Carbamazepine—Pain—Doxorubicin—urinary bladder cancer	2.81e-05	0.000251	CcSEcCtD
Carbamazepine—Abdominal pain—Epirubicin—urinary bladder cancer	2.81e-05	0.000251	CcSEcCtD
Carbamazepine—Body temperature increased—Epirubicin—urinary bladder cancer	2.81e-05	0.000251	CcSEcCtD
Carbamazepine—Hypersensitivity—Methotrexate—urinary bladder cancer	2.8e-05	0.00025	CcSEcCtD
Carbamazepine—Asthenia—Methotrexate—urinary bladder cancer	2.73e-05	0.000244	CcSEcCtD
Carbamazepine—Feeling abnormal—Doxorubicin—urinary bladder cancer	2.71e-05	0.000242	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	2.69e-05	0.00024	CcSEcCtD
Carbamazepine—Pruritus—Methotrexate—urinary bladder cancer	2.69e-05	0.00024	CcSEcCtD
Carbamazepine—Hypersensitivity—Epirubicin—urinary bladder cancer	2.62e-05	0.000234	CcSEcCtD
Carbamazepine—Urticaria—Doxorubicin—urinary bladder cancer	2.61e-05	0.000234	CcSEcCtD
Carbamazepine—Body temperature increased—Doxorubicin—urinary bladder cancer	2.6e-05	0.000232	CcSEcCtD
Carbamazepine—Abdominal pain—Doxorubicin—urinary bladder cancer	2.6e-05	0.000232	CcSEcCtD
Carbamazepine—Diarrhoea—Methotrexate—urinary bladder cancer	2.6e-05	0.000232	CcSEcCtD
Carbamazepine—Asthenia—Epirubicin—urinary bladder cancer	2.55e-05	0.000228	CcSEcCtD
Carbamazepine—Pruritus—Epirubicin—urinary bladder cancer	2.52e-05	0.000225	CcSEcCtD
Carbamazepine—Dizziness—Methotrexate—urinary bladder cancer	2.51e-05	0.000225	CcSEcCtD
Carbamazepine—Diarrhoea—Epirubicin—urinary bladder cancer	2.43e-05	0.000217	CcSEcCtD
Carbamazepine—Hypersensitivity—Doxorubicin—urinary bladder cancer	2.42e-05	0.000217	CcSEcCtD
Carbamazepine—Vomiting—Methotrexate—urinary bladder cancer	2.42e-05	0.000216	CcSEcCtD
Carbamazepine—Rash—Methotrexate—urinary bladder cancer	2.4e-05	0.000214	CcSEcCtD
Carbamazepine—Dermatitis—Methotrexate—urinary bladder cancer	2.39e-05	0.000214	CcSEcCtD
Carbamazepine—Headache—Methotrexate—urinary bladder cancer	2.38e-05	0.000213	CcSEcCtD
Carbamazepine—Asthenia—Doxorubicin—urinary bladder cancer	2.36e-05	0.000211	CcSEcCtD
Carbamazepine—Dizziness—Epirubicin—urinary bladder cancer	2.35e-05	0.00021	CcSEcCtD
Carbamazepine—Pruritus—Doxorubicin—urinary bladder cancer	2.33e-05	0.000208	CcSEcCtD
Carbamazepine—Vomiting—Epirubicin—urinary bladder cancer	2.26e-05	0.000202	CcSEcCtD
Carbamazepine—Nausea—Methotrexate—urinary bladder cancer	2.26e-05	0.000202	CcSEcCtD
Carbamazepine—Diarrhoea—Doxorubicin—urinary bladder cancer	2.25e-05	0.000201	CcSEcCtD
Carbamazepine—Rash—Epirubicin—urinary bladder cancer	2.24e-05	0.0002	CcSEcCtD
Carbamazepine—Dermatitis—Epirubicin—urinary bladder cancer	2.24e-05	0.0002	CcSEcCtD
Carbamazepine—Headache—Epirubicin—urinary bladder cancer	2.23e-05	0.000199	CcSEcCtD
Carbamazepine—Dizziness—Doxorubicin—urinary bladder cancer	2.18e-05	0.000194	CcSEcCtD
Carbamazepine—Nausea—Epirubicin—urinary bladder cancer	2.11e-05	0.000189	CcSEcCtD
Carbamazepine—Vomiting—Doxorubicin—urinary bladder cancer	2.09e-05	0.000187	CcSEcCtD
Carbamazepine—Rash—Doxorubicin—urinary bladder cancer	2.07e-05	0.000185	CcSEcCtD
Carbamazepine—Dermatitis—Doxorubicin—urinary bladder cancer	2.07e-05	0.000185	CcSEcCtD
Carbamazepine—Headache—Doxorubicin—urinary bladder cancer	2.06e-05	0.000184	CcSEcCtD
Carbamazepine—Nausea—Doxorubicin—urinary bladder cancer	1.95e-05	0.000175	CcSEcCtD
Carbamazepine—RALBP1—Signaling Pathways—PTEN—urinary bladder cancer	1.22e-05	0.000253	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—HPGDS—urinary bladder cancer	1.2e-05	0.000248	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—ENO2—urinary bladder cancer	1.2e-05	0.000248	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—TYMP—urinary bladder cancer	1.2e-05	0.000248	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	1.19e-05	0.000246	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—NAT1—urinary bladder cancer	1.19e-05	0.000246	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	1.19e-05	0.000246	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—GSTP1—urinary bladder cancer	1.18e-05	0.000244	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	1.17e-05	0.000242	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—TNF—urinary bladder cancer	1.17e-05	0.000242	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—EP300—urinary bladder cancer	1.17e-05	0.000241	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—GSTT1—urinary bladder cancer	1.16e-05	0.00024	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	1.16e-05	0.00024	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—KRAS—urinary bladder cancer	1.16e-05	0.00024	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	1.16e-05	0.00024	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	1.15e-05	0.000237	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—SRC—urinary bladder cancer	1.13e-05	0.000235	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PRSS3—urinary bladder cancer	1.13e-05	0.000234	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—NAT2—urinary bladder cancer	1.11e-05	0.000229	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	1.11e-05	0.000229	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—TYMS—urinary bladder cancer	1.1e-05	0.000227	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	1.09e-05	0.000225	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	1.08e-05	0.000224	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—NAT2—urinary bladder cancer	1.08e-05	0.000224	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—NCOR1—urinary bladder cancer	1.08e-05	0.000224	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—GSTM1—urinary bladder cancer	1.08e-05	0.000224	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	1.07e-05	0.000221	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	1.07e-05	0.000221	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	1.06e-05	0.000219	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.04e-05	0.000215	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—TYMP—urinary bladder cancer	1.04e-05	0.000215	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—GPX1—urinary bladder cancer	1.04e-05	0.000215	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—ERCC2—urinary bladder cancer	1.02e-05	0.000211	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	1.02e-05	0.000211	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—MYC—urinary bladder cancer	1.02e-05	0.00021	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	9.96e-06	0.000206	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—EGFR—urinary bladder cancer	9.94e-06	0.000206	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	9.9e-06	0.000205	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—HRAS—urinary bladder cancer	9.86e-06	0.000204	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	9.81e-06	0.000203	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	9.69e-06	0.000201	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—NQO1—urinary bladder cancer	9.66e-06	0.0002	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—MTHFR—urinary bladder cancer	9.57e-06	0.000198	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—RRM2—urinary bladder cancer	9.57e-06	0.000198	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—KRAS—urinary bladder cancer	9.39e-06	0.000194	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—NAT2—urinary bladder cancer	9.38e-06	0.000194	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—RRM2—urinary bladder cancer	9.35e-06	0.000193	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	9.29e-06	0.000192	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	9.26e-06	0.000192	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—TYMP—urinary bladder cancer	9.26e-06	0.000192	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	9.19e-06	0.00019	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—NAT1—urinary bladder cancer	9.19e-06	0.00019	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—TYMP—urinary bladder cancer	9.04e-06	0.000187	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	9.02e-06	0.000187	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	8.89e-06	0.000184	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	8.87e-06	0.000184	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—HPGDS—urinary bladder cancer	8.86e-06	0.000183	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—ENO2—urinary bladder cancer	8.86e-06	0.000183	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	8.67e-06	0.000179	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	8.66e-06	0.000179	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—ENO2—urinary bladder cancer	8.66e-06	0.000179	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—GSTT1—urinary bladder cancer	8.59e-06	0.000178	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	8.47e-06	0.000175	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—TYMP—urinary bladder cancer	8.44e-06	0.000175	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	8.41e-06	0.000174	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	8.4e-06	0.000174	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—NAT2—urinary bladder cancer	8.37e-06	0.000173	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—TP53—urinary bladder cancer	8.34e-06	0.000173	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	8.26e-06	0.000171	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	8.19e-06	0.00017	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—NAT2—urinary bladder cancer	8.17e-06	0.000169	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	8.11e-06	0.000168	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—RRM2—urinary bladder cancer	8.1e-06	0.000168	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	8.05e-06	0.000167	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—HRAS—urinary bladder cancer	7.98e-06	0.000165	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PPARG—urinary bladder cancer	7.76e-06	0.000161	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—NAT2—urinary bladder cancer	7.64e-06	0.000158	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	7.57e-06	0.000157	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—ENO2—urinary bladder cancer	7.5e-06	0.000155	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	7.5e-06	0.000155	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—TYMS—urinary bladder cancer	7.49e-06	0.000155	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	7.46e-06	0.000154	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—CREBBP—urinary bladder cancer	7.46e-06	0.000154	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	7.4e-06	0.000153	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	7.4e-06	0.000153	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	7.28e-06	0.000151	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	7.27e-06	0.000151	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	7.24e-06	0.00015	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—RRM2—urinary bladder cancer	7.23e-06	0.00015	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—TYMP—urinary bladder cancer	7.21e-06	0.000149	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	7.16e-06	0.000148	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	7.15e-06	0.000148	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—NQO1—urinary bladder cancer	7.14e-06	0.000148	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—GPX1—urinary bladder cancer	7.09e-06	0.000147	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—RRM2—urinary bladder cancer	7.06e-06	0.000146	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—NQO1—urinary bladder cancer	6.98e-06	0.000144	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	6.96e-06	0.000144	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	6.96e-06	0.000144	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	6.93e-06	0.000143	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	6.69e-06	0.000139	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—ENO2—urinary bladder cancer	6.69e-06	0.000139	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	6.66e-06	0.000138	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—RRM2—urinary bladder cancer	6.59e-06	0.000136	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	6.54e-06	0.000135	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—HPGDS—urinary bladder cancer	6.53e-06	0.000135	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—ENO2—urinary bladder cancer	6.53e-06	0.000135	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—NAT2—urinary bladder cancer	6.52e-06	0.000135	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	6.49e-06	0.000134	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	6.39e-06	0.000132	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—GSTT1—urinary bladder cancer	6.34e-06	0.000131	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PTGS2—urinary bladder cancer	6.1e-06	0.000126	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—ENO2—urinary bladder cancer	6.1e-06	0.000126	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	6.1e-06	0.000126	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	6.07e-06	0.000126	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—NQO1—urinary bladder cancer	6.05e-06	0.000125	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	5.96e-06	0.000123	CbGpPWpGaD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.93e-06	0.000123	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	5.92e-06	0.000123	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	5.87e-06	0.000121	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	5.83e-06	0.000121	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	5.82e-06	0.00012	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—RRM2—urinary bladder cancer	5.63e-06	0.000117	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	5.57e-06	0.000115	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—TYMS—urinary bladder cancer	5.54e-06	0.000115	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	5.47e-06	0.000113	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	5.47e-06	0.000113	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—TYMS—urinary bladder cancer	5.41e-06	0.000112	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—NQO1—urinary bladder cancer	5.4e-06	0.000112	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	5.35e-06	0.000111	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	5.35e-06	0.000111	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PTEN—urinary bladder cancer	5.32e-06	0.00011	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PPARG—urinary bladder cancer	5.3e-06	0.00011	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—NQO1—urinary bladder cancer	5.27e-06	0.000109	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—GPX1—urinary bladder cancer	5.24e-06	0.000108	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	5.24e-06	0.000108	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ENO2—urinary bladder cancer	5.22e-06	0.000108	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	5.22e-06	0.000108	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	5.19e-06	0.000107	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	5.15e-06	0.000106	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—GPX1—urinary bladder cancer	5.12e-06	0.000106	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.12e-06	0.000106	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	5.09e-06	0.000105	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—EP300—urinary bladder cancer	5.08e-06	0.000105	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	5.06e-06	0.000105	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	5.04e-06	0.000104	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	5.04e-06	0.000104	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	5.03e-06	0.000104	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.98e-06	0.000103	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—NQO1—urinary bladder cancer	4.92e-06	0.000102	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.88e-06	0.000101	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	4.84e-06	0.0001	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.77e-06	9.88e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	4.73e-06	9.78e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—TYMS—urinary bladder cancer	4.69e-06	9.7e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	4.63e-06	9.59e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	4.63e-06	9.59e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.57e-06	9.45e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	4.5e-06	9.31e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—GPX1—urinary bladder cancer	4.44e-06	9.18e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—GSTP1—urinary bladder cancer	4.39e-06	9.09e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	4.36e-06	9.01e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.35e-06	9.01e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	4.35e-06	8.99e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—NQO1—urinary bladder cancer	4.2e-06	8.7e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—TYMS—urinary bladder cancer	4.18e-06	8.66e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	4.17e-06	8.63e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.16e-06	8.61e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	4.14e-06	8.56e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	4.14e-06	8.56e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	4.1e-06	8.49e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	4.09e-06	8.47e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—TYMS—urinary bladder cancer	4.08e-06	8.45e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.08e-06	8.44e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—GSTM1—urinary bladder cancer	4.04e-06	8.35e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—NCOR1—urinary bladder cancer	4.04e-06	8.35e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	4.03e-06	8.33e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	4.03e-06	8.33e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.97e-06	8.22e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—GPX1—urinary bladder cancer	3.96e-06	8.2e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PPARG—urinary bladder cancer	3.92e-06	8.12e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	3.9e-06	8.08e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	3.89e-06	8.05e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—GPX1—urinary bladder cancer	3.87e-06	8e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PPARG—urinary bladder cancer	3.83e-06	7.93e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—TYMS—urinary bladder cancer	3.81e-06	7.89e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—ERCC2—urinary bladder cancer	3.8e-06	7.85e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	3.77e-06	7.8e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	3.77e-06	7.8e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	3.77e-06	7.8e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	3.68e-06	7.62e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	3.66e-06	7.56e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PTEN—urinary bladder cancer	3.64e-06	7.53e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GPX1—urinary bladder cancer	3.61e-06	7.47e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—MTHFR—urinary bladder cancer	3.57e-06	7.38e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.56e-06	7.36e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	3.55e-06	7.34e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	3.51e-06	7.26e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—EP300—urinary bladder cancer	3.47e-06	7.18e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.39e-06	7.02e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	3.33e-06	6.9e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PPARG—urinary bladder cancer	3.32e-06	6.87e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—TYMS—urinary bladder cancer	3.26e-06	6.75e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	3.24e-06	6.71e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	3.22e-06	6.67e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	3.22e-06	6.67e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	3.19e-06	6.6e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GPX1—urinary bladder cancer	3.09e-06	6.39e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	3.09e-06	6.38e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	3.03e-06	6.27e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	3.02e-06	6.24e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PPARG—urinary bladder cancer	2.96e-06	6.13e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PPARG—urinary bladder cancer	2.89e-06	5.99e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	2.85e-06	5.89e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	2.85e-06	5.89e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CREBBP—urinary bladder cancer	2.78e-06	5.75e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	2.71e-06	5.6e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PPARG—urinary bladder cancer	2.7e-06	5.59e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PTEN—urinary bladder cancer	2.69e-06	5.57e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PTEN—urinary bladder cancer	2.63e-06	5.44e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	2.61e-06	5.4e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	2.6e-06	5.37e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—EP300—urinary bladder cancer	2.57e-06	5.31e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	2.52e-06	5.21e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—EP300—urinary bladder cancer	2.51e-06	5.19e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	2.49e-06	5.15e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	2.49e-06	5.15e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	2.38e-06	4.93e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	2.34e-06	4.84e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	2.33e-06	4.82e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PPARG—urinary bladder cancer	2.31e-06	4.78e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PTEN—urinary bladder cancer	2.28e-06	4.71e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PTGS2—urinary bladder cancer	2.28e-06	4.71e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	2.22e-06	4.59e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	2.2e-06	4.55e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—EP300—urinary bladder cancer	2.17e-06	4.5e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	2.13e-06	4.4e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PTEN—urinary bladder cancer	2.03e-06	4.21e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PTEN—urinary bladder cancer	1.98e-06	4.11e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—EP300—urinary bladder cancer	1.94e-06	4.01e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—EP300—urinary bladder cancer	1.89e-06	3.92e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PTEN—urinary bladder cancer	1.85e-06	3.84e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	1.82e-06	3.76e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.78e-06	3.69e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—EP300—urinary bladder cancer	1.77e-06	3.66e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.71e-06	3.54e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PTEN—urinary bladder cancer	1.58e-06	3.28e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—EP300—urinary bladder cancer	1.51e-06	3.13e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	1.4e-06	2.9e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	1.22e-06	2.53e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—EP300—urinary bladder cancer	1.17e-06	2.41e-05	CbGpPWpGaD
